177 related articles for article (PubMed ID: 18413828)
1. Urinary biomarkers predict brain tumor presence and response to therapy.
Smith ER; Zurakowski D; Saad A; Scott RM; Moses MA
Clin Cancer Res; 2008 Apr; 14(8):2378-86. PubMed ID: 18413828
[TBL] [Abstract][Full Text] [Related]
2. Urinary MMP-2 and MMP-9 predict the presence of ovarian cancer in women with normal CA125 levels.
Coticchia CM; Curatolo AS; Zurakowski D; Yang J; Daniels KE; Matulonis UA; Moses MA
Gynecol Oncol; 2011 Nov; 123(2):295-300. PubMed ID: 21889192
[TBL] [Abstract][Full Text] [Related]
3. Matrix Metalloproteinase-9/Neutrophil Gelatinase-Associated Lipocalin Complex Activity in Human Glioma Samples Predicts Tumor Presence and Clinical Prognosis.
Liu MF; Hu YY; Jin T; Xu K; Wang SH; Du GZ; Wu BL; Li LY; Xu LY; Li EM; Xu HX
Dis Markers; 2015; 2015():138974. PubMed ID: 26663949
[TBL] [Abstract][Full Text] [Related]
4. Urinary ADAM12 and MMP-9/NGAL complex detect the presence of gastric cancer.
Shimura T; Dagher A; Sachdev M; Ebi M; Yamada T; Yamada T; Joh T; Moses MA
Cancer Prev Res (Phila); 2015 Mar; 8(3):240-8. PubMed ID: 25591790
[TBL] [Abstract][Full Text] [Related]
5. Urinary MMP-9/NGAL ratio as a potential marker of FSGS in nephrotic children.
Korzeniecka-Kozerska A; Wasilewska A; Tenderenda E; Sulik A; Cybulski K
Dis Markers; 2013; 34(5):357-62. PubMed ID: 23478276
[TBL] [Abstract][Full Text] [Related]
6. Using urinary bFGF and TIMP3 levels to predict the presence of juvenile pilocytic astrocytoma and establish a distinct biomarker signature.
Pricola Fehnel K; Duggins-Warf M; Zurakowski D; McKee-Proctor M; Majumder R; Raber M; Han X; Smith ER
J Neurosurg Pediatr; 2016 Oct; 18(4):396-407. PubMed ID: 27314542
[TBL] [Abstract][Full Text] [Related]
7. Urine biomarkers may someday detect even distant tumors.
Schmidt C
J Natl Cancer Inst; 2009 Jan; 101(1):8-10. PubMed ID: 19116386
[No Abstract] [Full Text] [Related]
8. The matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients.
Fernández CA; Yan L; Louis G; Yang J; Kutok JL; Moses MA
Clin Cancer Res; 2005 Aug; 11(15):5390-5. PubMed ID: 16061852
[TBL] [Abstract][Full Text] [Related]
9. A novel approach to using matrix metalloproteinases for bladder cancer.
Fernández CA; Wszolek MF; Loughlin KR; Libertino JA; Summerhayes IC; Shuber AP
J Urol; 2009 Nov; 182(5):2188-94. PubMed ID: 19758628
[TBL] [Abstract][Full Text] [Related]
10. Tumor-specific urinary matrix metalloproteinase fingerprinting: identification of high molecular weight urinary matrix metalloproteinase species.
Roy R; Louis G; Loughlin KR; Wiederschain D; Kilroy SM; Lamb CC; Zurakowski D; Moses MA
Clin Cancer Res; 2008 Oct; 14(20):6610-7. PubMed ID: 18927302
[TBL] [Abstract][Full Text] [Related]
11. Urinary MMP-9/NGAL complex in children with acute cystitis.
Hatipoglu S; Sevketoglu E; Gedikbasi A; Yilmaz A; Kiyak A; Mulazimoglu M; Aydogan G; Ozpacaci T
Pediatr Nephrol; 2011 Aug; 26(8):1263-8. PubMed ID: 21556719
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of neutrophil gelatinase-associated lipocalin/matrix metalloproteinase-9 pathway in transitional cell carcinoma of the bladder.
Candido S; Di Maso M; Serraino D; McCubrey JA; Bortolus R; Zanin M; Battiston M; Salemi R; Libra M; Polesel J
Tumour Biol; 2016 Jul; 37(7):9855-63. PubMed ID: 26810191
[TBL] [Abstract][Full Text] [Related]
13. Urine vascular biomarkers in Sturge-Weber syndrome.
Sreenivasan AK; Bachur CD; Lanier KE; Curatolo AS; Connors SM; Moses MA; Comi AM
Vasc Med; 2013 Jun; 18(3):122-8. PubMed ID: 23720035
[TBL] [Abstract][Full Text] [Related]
14. Increased urinary lipocalin-2 reflects matrix metalloproteinase-9 activity in chronic hepatitis C with hepatic fibrosis.
Kim JW; Lee SH; Jeong SH; Kim H; Ahn KS; Cho JY; Yoon YS; Han HS
Tohoku J Exp Med; 2010 Dec; 222(4):319-27. PubMed ID: 21150136
[TBL] [Abstract][Full Text] [Related]
15. Disease and gender-specific dysregulation of NGAL and MMP-9 in type 1 diabetes mellitus.
Thrailkill KM; Moreau CS; Cockrell GE; Jo CH; Bunn RC; Morales-Pozzo AE; Lumpkin CK; Fowlkes JL
Endocrine; 2010 Apr; 37(2):336-43. PubMed ID: 20960272
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil gelatinase-associated lipocalin is expressed in osteoarthritis and forms a complex with matrix metalloproteinase 9.
Gupta K; Shukla M; Cowland JB; Malemud CJ; Haqqi TM
Arthritis Rheum; 2007 Oct; 56(10):3326-35. PubMed ID: 17907186
[TBL] [Abstract][Full Text] [Related]
17. The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL.
Yan L; Borregaard N; Kjeldsen L; Moses MA
J Biol Chem; 2001 Oct; 276(40):37258-65. PubMed ID: 11486009
[TBL] [Abstract][Full Text] [Related]
18. Urine neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in critically ill children: a prospective cohort study.
Zappitelli M; Washburn KK; Arikan AA; Loftis L; Ma Q; Devarajan P; Parikh CR; Goldstein SL
Crit Care; 2007; 11(4):R84. PubMed ID: 17678545
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel non-invasive biomarkers of urinary chronic pelvic pain syndrome: findings from the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network.
Dagher A; Curatolo A; Sachdev M; Stephens AJ; Mullins C; Landis JR; van Bokhoven A; El-Hayek A; Froehlich JW; Briscoe AC; Roy R; Yang J; Pontari MA; Zurakowski D; Lee RS; Moses MA;
BJU Int; 2017 Jul; 120(1):130-142. PubMed ID: 28263447
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9) prognostic value in stage I colorectal carcinoma.
Barresi V; Reggiani-Bonetti L; Di Gregorio C; Vitarelli E; Ponz De Leon M; Barresi G
Pathol Res Pract; 2011 Aug; 207(8):479-86. PubMed ID: 21726963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]